{"id":17681,"date":"2018-10-14T22:48:54","date_gmt":"2018-10-14T21:48:54","guid":{"rendered":"https:\/\/diarisanitat.cat\/?p=17681"},"modified":"2018-10-14T22:48:54","modified_gmt":"2018-10-14T21:48:54","slug":"18-metges-van-rebre-mes-de-50-000-euros-cadascun-duna-sola-farmaceutica-el-2017","status":"publish","type":"post","link":"https:\/\/amazing-bassi.82-223-8-23.plesk.page\/index.php\/2018\/10\/14\/18-metges-van-rebre-mes-de-50-000-euros-cadascun-duna-sola-farmaceutica-el-2017\/","title":{"rendered":"18 metges van rebre m\u00e9s de 50.000 euros cadascun d’una sola farmac\u00e8utica el 2017"},"content":{"rendered":"

Les farmac\u00e8utiques van gastar 182 milions i mig el 2017 en pagaments a metges pels seus serveis o per assumir els costos d’entrades a congressos i viatges, unes xifres molt similars a l’any anterior. \u00c9s el que la ind\u00fastria engloba sota l’eufemisme de transfer\u00e8ncies de valor. Per\u00f2 no tots els que van rebre pagaments o invitacions a congressos ho van fer al mateix nivell. 18 metges van sumar en el seu haver, d’un sol laboratori i en un sol any, m\u00e9s de 50.000 euros. S\u00f3n una\u00a0minim\u00edssima\u00a0part dels 253.796 metges col\u00b7legiats en tot el pa\u00eds.<\/p>\n

Si analitzem aquestes relacions \u00faniques entre un laboratori i un metge, les xifres van des d’aquells que superen per poc aquest tall dels 50.000 euros i aquells que gaireb\u00e9 toquen els 100.000, com \u00e9s el cas dels m\u00e9s de 98.000 euros que\u00a0Bayer\u00a0va destinar al doctor Jordi Bruix. I tot aix\u00f2 sense explicar el que van rebre d’altres laboratoris, que fa que professionals com\u00a0Mar\u00eda\u00a0Victoria\u00a0Mateos\u00a0sumi gaireb\u00e9 170.000 euros; o\u00a0Luis\u00a0Puig, m\u00e9s de 150.000.<\/p>\n

Metges que van rebre m\u00e9s de 50.000 \u20ac d’una \u00fanica\u00a0farmac\u00e8utica\u00a0el 2017:<\/p>\n

Centres p\u00fablics<\/p>\n

Centres privats<\/p>\n

\n
\n

Jordi Bruix Tud\u00f3<\/h4>\n

Oncologia hep\u00e0tica – Hospital Cl\u00ednic<\/p>\n

\n
BAYER\u00a0(98%)<\/div>\n<\/div>\n<\/div>\n
\n

Mar\u00eda Victoria Mateos Manteca<\/h4>\n

Hematologia – Hospital de Salamanca<\/p>\n

\n
JANSSEN-CILAG\u00a0(51%)<\/div>\n<\/div>\n<\/div>\n
\n

Antonio Martorell Calatayud<\/h4>\n

Dermatologia – Hospital de Manises<\/p>\n

\n
ABBVIE\u00a0(86%)<\/div>\n<\/div>\n<\/div>\n
\n

Enrique Grande Pulido<\/h4>\n

Oncologia – MD Anderson Madrid<\/p>\n

\n
PFIZER\u00a0(57%)<\/div>\n<\/div>\n<\/div>\n
\n

Anna Sureda Balari<\/h4>\n

Hematologia cl\u00ednica – Institut Catal\u00e0 d’Oncologia<\/p>\n

\n
TAKEDA\u00a0(72%)<\/div>\n<\/div>\n<\/div>\n
\n

Mar\u00eda Elisa Reig Monz\u00f3n<\/h4>\n

Oncologia hep\u00e0tica – Hospital Cl\u00ednic<\/p>\n

\n
BAYER\u00a0(96%)<\/div>\n<\/div>\n<\/div>\n
\n

Emiliano Calvo Aller<\/h4>\n

START Madrid – Centro Integral Oncol\u00f2gic Clara Campal<\/p>\n

\n
NOVARTIS\u00a0(90%)<\/div>\n<\/div>\n<\/div>\n
\n

Jerzy Aleksander Krupinski Bielecki<\/h4>\n

Neurologia – Hospital M\u00fatua de Terrassa<\/p>\n

\n
FERRER\u00a0(99%)<\/div>\n<\/div>\n<\/div>\n
\n

Marc Miravitlles Fern\u00e1ndez<\/h4>\n

Neumologia – Hospital Vall d’Hebr\u00f3n<\/p>\n

\n
NOVARTIS\u00a0(54%)<\/div>\n<\/div>\n<\/div>\n
\n

Eduard Montanya M\u00edas<\/h4>\n

Endocrinolog\u00eda y Nutrici\u00f3n – Hospital de Bellvitge<\/p>\n

\n
NOVO NORDISK\u00a0(82%)<\/div>\n<\/div>\n<\/div>\n
\n

Luis Puig Sanz<\/h4>\n

Dermatologia – Hospital de Sant Pau<\/p>\n

\n
LILLY\u00a0(39%)<\/div>\n<\/div>\n<\/div>\n
\n

Ana Lluch Hern\u00e1ndez<\/h4>\n

Oncologia – Hospital Cl\u00ednico Universitario de Valencia<\/p>\n

\n
ROCHE\u00a0(68%)<\/div>\n<\/div>\n<\/div>\n
\n

Javier Puente V\u00e1zquez<\/h4>\n

Oncolog\u00eda – Hospital Cl\u00ednico San Carlos<\/p>\n

\n
PFIZER\u00a0(66%)<\/div>\n<\/div>\n<\/div>\n
\n

Antonio Salar Silvestre<\/h4>\n

Hematolog\u00eda – Hospital del Mar de Barcelona<\/p>\n

\n
ROCHE\u00a0(82%)<\/div>\n<\/div>\n<\/div>\n
\n

Miguel Cordero Coma<\/h4>\n

Oftalmologia – Hospital de Le\u00f3n<\/p>\n

\n
ABBVIE\u00a0(94%)<\/div>\n<\/div>\n<\/div>\n
\n

Jes\u00fas Garc\u00eda Foncillas<\/h4>\n

Oncologia – Hospital Fundaci\u00f3n Jim\u00e9nez D\u00edaz<\/p>\n<\/div>\n

MERCK\u00a0(98%)<\/div>\n
\n

Francisco Javier Nistal Rodr\u00edguez<\/h4>\n

Traumatologia – Hospital R\u00edo Hortega de Valladolid<\/p>\n

\n
LILLY\u00a0(99%)<\/div>\n<\/div>\n<\/div>\n
\n

Marcos Meseguer Escriv\u00e1<\/h4>\n

Embriologia – IVI Valencia<\/p>\n

\n
MERCK\u00a0(92%)<\/div>\n<\/div>\n<\/div>\n
\n
50.000 \u20ac<\/div>\n
100.000 \u20ac<\/div>\n
150.000 \u20ac<\/div>\n<\/div>\n<\/div>\n
\n
<\/div>\n
\n
\n

Jordi Bruix Tud\u00f3<\/h4>\n

Oncologia hep\u00e0tica – Hospital Cl\u00ednic (centre p\u00fablic). \u00c9s membre de la xarxa d’experts de l’Ag\u00e8ncia Espanyola de Medicaments i Productes Sanitaris (AEMPS per les seves sigles en castell\u00e0) i de l’Ag\u00e8ncia Europea de Medicaments (EMA).<\/p>\n<\/div>\n

\n
<\/div>\n
Ha rebut 100.006 \u20ac\u00a0de 2 farmac\u00e8utiques, dels quals el 98% prov\u00e9 de\u00a0BAYER.<\/div>\n\n\n\n\n
BAYER<\/td>\n98.006 \u20ac<\/td>\n<\/tr>\n
EISAI<\/td>\n2.000 \u20ac<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
\n

Mar\u00eda Victoria Mateos Manteca<\/h4>\n

Hematologia – Hospital de Salamanca (centre p\u00fablic)<\/p>\n

Ha rebut 169.013 \u20ac\u00a0de 4 farmac\u00e8utiques, dels quals el 51% prov\u00e9 de JANSSEN-CILAG.<\/div>\n\n\n\n\n\n\n
JANSSEN-CILAG<\/td>\n85.653 \u20ac<\/td>\n<\/tr>\n
CELGENE<\/td>\n38.052 \u20ac<\/td>\n<\/tr>\n
AMGEN<\/td>\n36.703 \u20ac<\/td>\n<\/tr>\n
TAKEDA<\/td>\n8.606 \u20ac<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
\n

Antonio Martorell Calatayud<\/h4>\n

Dermatologia – Hospital de Manises (centre privat)<\/p>\n

Ha rebut 97.740 \u20ac\u00a0de 8 farmac\u00e8utiques, dels quals el 86% prov\u00e9 d’ABBVIE.<\/div>\n\n\n\n\n\n\n\n\n\n\n
ABBVIE<\/td>\n83.859 \u20ac<\/td>\n<\/tr>\n
JANSSEN-CILAG<\/td>\n6.301 \u20ac<\/td>\n<\/tr>\n
LILLY<\/td>\n2.151 \u20ac<\/td>\n<\/tr>\n
CELGENE<\/td>\n1.908 \u20ac<\/td>\n<\/tr>\n
LEO PHARMA<\/td>\n1.529 \u20ac<\/td>\n<\/tr>\n
NOVARTIS<\/td>\n1.325 \u20ac<\/td>\n<\/tr>\n
PFIZER<\/td>\n396 \u20ac<\/td>\n<\/tr>\n
ALMIRALL<\/td>\n270 \u20ac<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
\n

Enrique Grande Pulido<\/h4>\n

Oncologia – MD Anderson Madrid (centre privat).<\/p>\n

Ha rebut 141.741 \u20ac\u00a0de 12 farmac\u00e8utiques, dels quals el 57% prov\u00e9 de PFIZER.<\/div>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
PFIZER<\/td>\n81.182 \u20ac<\/td>\n<\/tr>\n
ROCHE<\/td>\n20.779 \u20ac<\/td>\n<\/tr>\n
BRISTOL-MYERS SQUIBB<\/td>\n19.798 \u20ac<\/td>\n<\/tr>\n
EISAI<\/td>\n7.037 \u20ac<\/td>\n<\/tr>\n
IPSEN<\/td>\n4.374 \u20ac<\/td>\n<\/tr>\n
MSD<\/td>\n2.150 \u20ac<\/td>\n<\/tr>\n
BAYER<\/td>\n1.981 \u20ac<\/td>\n<\/tr>\n
PIERRE FABRE<\/td>\n1.258 \u20ac<\/td>\n<\/tr>\n
ASTELLAS<\/td>\n984 \u20ac<\/td>\n<\/tr>\n
JANSSEN-CILAG<\/td>\n924 \u20ac<\/td>\n<\/tr>\n
NOVARTIS<\/td>\n675 \u20ac<\/td>\n<\/tr>\n
ASTRAZENECA<\/td>\n600 \u20ac<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
\n

Anna Sureda Balari<\/h4>\n

Hematologia cl\u00ednica – Institut Catal\u00e0 d’Oncologia (centre p\u00fablic).<\/p>\n

Ha rebut 108.294 \u20ac\u00a0de 9 farmac\u00e8utiques, dels quals el 72% prov\u00e9 de TAKEDA.<\/div>\n\n\n\n\n\n\n\n\n\n\n\n
TAKEDA<\/td>\n77.728 \u20ac<\/td>\n<\/tr>\n
BRISTOL-MYERS SQUIBB<\/td>\n8.481 \u20ac<\/td>\n<\/tr>\n
ROCHE<\/td>\n7.801 \u20ac<\/td>\n<\/tr>\n
MSD<\/td>\n4.717 \u20ac<\/td>\n<\/tr>\n
JANSSEN-CILAG<\/td>\n3.014 \u20ac<\/td>\n<\/tr>\n
GILEAD<\/td>\n2.295 \u20ac<\/td>\n<\/tr>\n
CELGENE<\/td>\n2.277 \u20ac<\/td>\n<\/tr>\n
NOVARTIS<\/td>\n1.080 \u20ac<\/td>\n<\/tr>\n
AMGEN<\/td>\n900 \u20ac<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
\n

Mar\u00eda Elisa Reig Monz\u00f3n<\/h4>\n

Oncologia hep\u00e0tica – Hospital Cl\u00ednic (centre p\u00fablice). \u00c9s membre de la xarxa de l’Ag\u00e8ncia Espanyola de Medicaments i Productes Sanitaris (AEMPS per les seves sigles en castell\u00e0). Ha rebut 75.589 \u20ac\u00a0de 2 farmac\u00e8utiques, dels quals el 96% prov\u00e9 de\u00a0BAYER.<\/p>\n\n\n\n\n
BAYER<\/td>\n72.558 \u20ac<\/td>\n<\/tr>\n
BRISTOL-MYERS SQUIBB<\/td>\n3.031 \u20ac<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
\n

Emiliano Calvo Aller<\/h4>\n

START Madrid – Centre Integral Oncol\u00f2gic Clara Campal (centre privat*)<\/p>\n

Ha rebut 80.096 \u20ac\u00a0de 4 farmac\u00e8utiques, dels quals el 90% prov\u00e9 de NOVARTIS.<\/div>\n\n\n\n\n\n\n
NOVARTIS<\/td>\n71.952 \u20ac<\/td>\n<\/tr>\n
ABBVIE<\/td>\n4.514 \u20ac<\/td>\n<\/tr>\n
ROCHE<\/td>\n2.505 \u20ac<\/td>\n<\/tr>\n
MSD<\/td>\n1.125 \u20ac<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
\n

Jerzy Aleksander Krupinski Bielecki<\/h4>\n

Neurologia – Hospital M\u00fatua de Terrassa (centre concertat)<\/p>\n

Ha rebut 68.688 \u20ac\u00a0de 3 farmac\u00e8utiques, dels quals el 99% prov\u00e9 de\u00a0FERRER.<\/div>\n\n\n\n\n\n
FERRER<\/td>\n67.664 \u20ac<\/td>\n<\/tr>\n
BAYER<\/td>\n706 \u20ac<\/td>\n<\/tr>\n
UCB<\/td>\n318 \u20ac<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
\n

Marc Miravitlles Fern\u00e1ndez<\/h4>\n

Neumologia – Hospital Vall d’Hebr\u00f3n (centre p\u00fablic).<\/p>\n

Ha rebut 117.887 \u20ac\u00a0de 8 farmac\u00e8utiques, dels quals el 54% prov\u00e9 de NOVARTIS.<\/div>\n\n\n\n\n\n\n\n\n\n\n
NOVARTIS<\/td>\n64.207 \u20ac<\/td>\n<\/tr>\n
BOEHRINGER INGELHEIM<\/td>\n23.849 \u20ac<\/td>\n<\/tr>\n
GLAXOSMITHKLINE<\/td>\n9.529 \u20ac<\/td>\n<\/tr>\n
MENARINI<\/td>\n8.353 \u20ac<\/td>\n<\/tr>\n
CHIESI<\/td>\n5.200 \u20ac<\/td>\n<\/tr>\n
ASTRAZENECA<\/td>\n2.584 \u20ac<\/td>\n<\/tr>\n
ESTEVE<\/td>\n2.400 \u20ac<\/td>\n<\/tr>\n
GEBRO PHARMA<\/td>\n1.765 \u20ac<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
\n

Eduard Montanya M\u00edas<\/h4>\n

Endocrinologia i Nutrici\u00f3 – Hospital de Bellvitge (centre p\u00fablic)<\/p>\n

Ha rebut 77.342 \u20ac\u00a0de 6 farmac\u00e8utiques, dels quals el 82% prov\u00e9 de\u00a0NOVO NORDISK.<\/div>\n\n\n\n\n\n\n\n\n
NOVO NORDISK<\/td>\n63.609 \u20ac<\/td>\n<\/tr>\n
ASTRAZENECA<\/td>\n6.685 \u20ac<\/td>\n<\/tr>\n
MSD<\/td>\n3.277 \u20ac<\/td>\n<\/tr>\n
SERVIER<\/td>\n2.552 \u20ac<\/td>\n<\/tr>\n
MENARINI<\/td>\n1.004 \u20ac<\/td>\n<\/tr>\n
ESTEVE<\/td>\n215 \u20ac<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
\n

Luis Puig Sanz<\/h4>\n

Dermatologia – Hospital de Sant Pau (centre p\u00fablic).<\/p>\n

Ha rebut 151.863 \u20ac\u00a0de 10 farmac\u00e8utiques, dels quals el 39% prov\u00e9 de\u00a0LILLY.<\/div>\n\n\n\n\n\n\n\n\n\n\n\n\n
LILLY<\/td>\n59.464 \u20ac<\/td>\n<\/tr>\n
JANSSEN-CILAG<\/td>\n44.675 \u20ac<\/td>\n<\/tr>\n
NOVARTIS<\/td>\n16.798 \u20ac<\/td>\n<\/tr>\n
ALMIRALL<\/td>\n8.043 \u20ac<\/td>\n<\/tr>\n
LEO PHARMA<\/td>\n7.416 \u20ac<\/td>\n<\/tr>\n
BIOGEN<\/td>\n5.991 \u20ac<\/td>\n<\/tr>\n
ABBVIE<\/td>\n5.221 \u20ac<\/td>\n<\/tr>\n
SANDOZ<\/td>\n2.903 \u20ac<\/td>\n<\/tr>\n
PFIZER<\/td>\n1.286 \u20ac<\/td>\n<\/tr>\n
PIERRE FABRE<\/td>\n65 \u20ac<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
\n

Ana Lluch Hern\u00e1ndez<\/h4>\n

Oncologia – Hospital Cl\u00ednic Universitari de Val\u00e8ncia (centre p\u00fablic).<\/p>\n

Ha rebut 81.404 \u20ac\u00a0de 5 farmac\u00e8utiques, dels quals el 68% prov\u00e9 de\u00a0ROCHE.<\/div>\n\n\n\n\n\n\n\n
ROCHE<\/td>\n55.697 \u20ac<\/td>\n<\/tr>\n
NOVARTIS<\/td>\n18.408 \u20ac<\/td>\n<\/tr>\n
PFIZER<\/td>\n5.324 \u20ac<\/td>\n<\/tr>\n
EISAI<\/td>\n1.000 \u20ac<\/td>\n<\/tr>\n
ASTRAZENECA<\/td>\n975 \u20ac<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
\n

Javier Puente V\u00e1zquez<\/h4>\n

Oncologia – Hospital Cl\u00ednico San Carlos (centro p\u00fablico)<\/p>\n

Ha rebut 84.087 \u20ac\u00a0de 15 farmac\u00e8utiques, dels quals el 66% prov\u00e9 de\u00a0PFIZER.<\/div>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
PFIZER<\/td>\n55.388 \u20ac<\/td>\n<\/tr>\n
ROCHE<\/td>\n5.500 \u20ac<\/td>\n<\/tr>\n
MSD<\/td>\n3.524 \u20ac<\/td>\n<\/tr>\n
ASTRAZENECA<\/td>\n2.912 \u20ac<\/td>\n<\/tr>\n
IPSEN<\/td>\n2.512 \u20ac<\/td>\n<\/tr>\n
PIERRE FABRE<\/td>\n2.384 \u20ac<\/td>\n<\/tr>\n
BRISTOL-MYERS SQUIBB<\/td>\n1.966 \u20ac<\/td>\n<\/tr>\n
BOEHRINGER INGELHEIM<\/td>\n1.885 \u20ac<\/td>\n<\/tr>\n
BAYER<\/td>\n1.412 \u20ac<\/td>\n<\/tr>\n
ASTELLAS<\/td>\n1.336 \u20ac<\/td>\n<\/tr>\n
MERCK<\/td>\n1.200 \u20ac<\/td>\n<\/tr>\n
NOVARTIS<\/td>\n1.180 \u20ac<\/td>\n<\/tr>\n
KYOWA KIRIN<\/td>\n1.088 \u20ac<\/td>\n<\/tr>\n
CELGENE<\/td>\n1.050 \u20ac<\/td>\n<\/tr>\n
LILLY<\/td>\n750 \u20ac<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
\n

Antonio Salar Silvestre<\/h4>\n

Hematologia – Hospital del Mar de Barcelona (centre p\u00fablic).<\/p>\n

Ha rebut 64.783 \u20ac\u00a0de 5 farmac\u00e8utiques, dels quals el 82% prov\u00e9 de\u00a0ROCHE.<\/div>\n\n\n\n\n\n\n\n
ROCHE<\/td>\n53.023 \u20ac<\/td>\n<\/tr>\n
JANSSEN-CILAG<\/td>\n7.251 \u20ac<\/td>\n<\/tr>\n
CELGENE<\/td>\n3.780 \u20ac<\/td>\n<\/tr>\n
SERVIER<\/td>\n566 \u20ac<\/td>\n<\/tr>\n
TAKEDA<\/td>\n163 \u20ac<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
\n

Miguel Cordero Coma<\/h4>\n

Oftalmologia – Hospital de Le\u00f3n (centre p\u00fablic) i cl\u00ednica privada. \u00c9s membre de la xarxa d’experts de l’Ag\u00e8ncia Espanyola de Medicaments i Productes Sanitaris (AEMPS)<\/p>\n

Ha rebut 56.135 \u20ac\u00a0de 4 farmac\u00e8utiques, dels quals el 94% prov\u00e9 de\u00a0ABBVIE.<\/div>\n\n\n\n\n\n\n
ABBVIE<\/td>\n52.732 \u20ac<\/td>\n<\/tr>\n
ALLERGAN<\/td>\n2.413 \u20ac<\/td>\n<\/tr>\n
UCB<\/td>\n605 \u20ac<\/td>\n<\/tr>\n
NOVARTIS<\/td>\n385 \u20ac<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
\n

Jes\u00fas Garc\u00eda Foncillas<\/h4>\n

Oncologia – Hospital Fundaci\u00f3n Jim\u00e9nez D\u00edaz (centre concertat).<\/p>\n

Ha rebut 51.829 \u20ac\u00a0de 4 farmac\u00e8utiques, dels quals el 98% prov\u00e9 de\u00a0MERCK.<\/div>\n\n\n\n\n\n\n
MERCK<\/td>\n50.542 \u20ac<\/td>\n<\/tr>\n
AMGEN<\/td>\n910 \u20ac<\/td>\n<\/tr>\n
LILLY<\/td>\n270 \u20ac<\/td>\n<\/tr>\n
ROCHE<\/td>\n106 \u20ac<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
\n

Francisco Javier Nistal Rodr\u00edguez<\/h4>\n

Traumatologia – Hospital R\u00edo Hortega de Valladolid (centre p\u00fablic) i cl\u00ednica privada.<\/p>\n

Ha rebut 50.524 \u20ac\u00a0de 2 farmac\u00e8utiques, dels quals el\u00a0 99% prov\u00e9 de\u00a0LILLY.<\/div>\n\n\n\n\n
LILLY<\/td>\n50.261 \u20ac<\/td>\n<\/tr>\n
MUNDIPHARMA<\/td>\n263 \u20ac<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
\n

Marcos Meseguer Escriv\u00e1<\/h4>\n

Embriologia – IVI Val\u00e8ncia (centre privat*)<\/p>\n

Ha rebut 54.688 \u20ac\u00a0de 3 farmac\u00e8utiques, dels quals el\u00a0 92% prov\u00e9 de\u00a0MERCK.<\/div>\n\n\n\n\n\n
MERCK<\/td>\n50.124 \u20ac<\/td>\n<\/tr>\n
MSD<\/td>\n3.149 \u20ac<\/td>\n<\/tr>\n
DIATER<\/td>\n1.415 \u20ac<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n

Aquest \u00e9s un article de eldiario.es<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Les farmac\u00e8utiques van gastar 182 milions i mig el 2017 en pagaments a metges pels seus serveis o per assumir els costos d’entrades a congressos i viatges, unes xifres molt similars a l’any anterior. \u00c9s el que la ind\u00fastria engloba sota l’eufemisme de transfer\u00e8ncies de valor. Per\u00f2 no tots els que van rebre pagaments o […]<\/p>\n","protected":false},"author":254,"featured_media":17488,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[364,365,560,194],"class_list":["post-17681","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-recerca","tag-farmaceutiques","tag-incentius","tag-investigacio","tag-recerca"],"_links":{"self":[{"href":"https:\/\/amazing-bassi.82-223-8-23.plesk.page\/index.php\/wp-json\/wp\/v2\/posts\/17681","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/amazing-bassi.82-223-8-23.plesk.page\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/amazing-bassi.82-223-8-23.plesk.page\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/amazing-bassi.82-223-8-23.plesk.page\/index.php\/wp-json\/wp\/v2\/users\/254"}],"replies":[{"embeddable":true,"href":"https:\/\/amazing-bassi.82-223-8-23.plesk.page\/index.php\/wp-json\/wp\/v2\/comments?post=17681"}],"version-history":[{"count":0,"href":"https:\/\/amazing-bassi.82-223-8-23.plesk.page\/index.php\/wp-json\/wp\/v2\/posts\/17681\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/amazing-bassi.82-223-8-23.plesk.page\/index.php\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/amazing-bassi.82-223-8-23.plesk.page\/index.php\/wp-json\/wp\/v2\/media?parent=17681"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/amazing-bassi.82-223-8-23.plesk.page\/index.php\/wp-json\/wp\/v2\/categories?post=17681"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/amazing-bassi.82-223-8-23.plesk.page\/index.php\/wp-json\/wp\/v2\/tags?post=17681"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}